Politics Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches November 15, 2025 Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion deal, accelerating efforts to broaden…
